On November 11, as of the close of Hong Kong stocks, the Hang Seng Index fell 1.45%to 20426.93 points.Hima Medical (03309.HK) closed at HK $ 2.14/share, down 6.55%, the transaction volume of 5.728 million shares, and the turnover of HK $ 12.879 million, with an amplitude of 6.55%.
In the past month, Hima Medical has fallen by 14.87%, a cumulative decline of 33.43%this year, and a 21.59%increase in the Hang Seng Index.
Financial data shows that as of June 30, 2024, Hima Medical achieved total operating income of 842 million yuan, a year -on -year decrease of 2.92%; net profit attributable to mother3.38%; gross profit margin 31.34%, asset -liability ratio of 27.87%.
In terms of institutional rating, there is currently no proposal to invest investment rating for the stock.
In terms of industry valuation, the average value -in -earnings ratio (TTM) of medical care equipment and service industry is 32.61 times, and the industry is 5.29 times.Heima Medical P / E ratio is 45.64 times, and the industry ranks 44th; other superstar Medical Holdings (02393.HK) is 0.14 times, Yongsheng Medical (01612.HK) is 4.14 times, Global Medical (02666.HK) is 4.19 times, and the new is new.Century Medical (01518.HK) was 4.78 times, and Ruici Medical (01526.HK) was 5.29 times.
Data show that Hima Medical Holding Co., Ltd.The headquarters is located in Hong Kong and establishes a chain hospital network in many major cities in the Mainland.Hima took the ophthalmology as the core and gradually expanded the business scope to different specialty services. Adhering to the concept of "patient -centric", he was committed to providing professional high -quality, convenient and reasonable medical services.Hima was founded by Dr. Lin Shunchao. Since the establishment of the first ophthalmology center in Hong Kong in 2012, the business has continued to thrive.The Group currently has 70 medical institutions in Hong Kong and the Mainland, with a total service area of more than 56,000 square meters, including more than 40 specialty and other medical facilities in Hong Kong; the numberThere are many cities including Shenzhen and Guangzhou, such as Shenzhen and Guangzhou, Beijing, Shanghai, and Kunming, which facilitates that mainland residents have obtained Himas Hong Kong -style medical services in the nearest.Hima has formulated the EYE+ strategy, which starts from the ophthalmology department to the field of diversified medical care to better meet the citizens needs for specialist medical services.The Hong Kong business of the Group has expanded to cover multiple specialty services such as ophthalmology, dental, integer surgery/medical beauty, family medicine and oncology.In the country, Hima replicated the successful introduction of the mainlands ophthalmology model to the development of the dental market, and exerted the synergistic effect with the ophthalmology to expand the target customer base.Professional talents are the cornerstone of high -quality medical care. Hima, a listed medical group founded and managed by doctors, upholds rigorous professional ethics.The Group has more than 3,000 employees. With its rich experience and unique expertise, the professional medical team uses advanced and perfect medical equipment to adopt the most suitable treatment plan for patients to design the most suitable treatment plan for patients.The Group will continue to move towards diversified medical services in the future. The goal is to establish a multi -specialized Hong Kong -style specialty medical service platform in the Greater Bay Area and major mainland cities to protect the health of the citizens.
Reminder
On November 8, 2024, the company repurchased at HK $ 2.29-2.3 per share248,000 shares, the repurchase amount of 568,200 Hong Kong dollars
(the above content is a public message based on the financial community, which is intelligently generated by procedures or algorithms.p>
This article comes from: the financial industry
Author: market
